These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28184943)

  • 1. Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay.
    Baert A; Depuydt J; Van Maerken T; Poppe B; Malfait F; Van Damme T; De Nobele S; Perletti G; De Leeneer K; Claes KB; Vral A
    Oncol Rep; 2017 Mar; 37(3):1379-1386. PubMed ID: 28184943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation.
    Baert A; Depuydt J; Van Maerken T; Poppe B; Malfait F; Storm K; van den Ende J; Van Damme T; De Nobele S; Perletti G; De Leeneer K; Claes KB; Vral A
    Breast Cancer Res; 2016 May; 18(1):52. PubMed ID: 27184744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.
    Baeyens A; Thierens H; Claes K; Poppe B; de Ridder L; Vral A
    Int J Radiat Biol; 2004 Oct; 80(10):745-56. PubMed ID: 15799620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility.
    Barwell J; Pangon L; Georgiou A; Kesterton I; Langman C; Arden-Jones A; Bancroft E; Salmon A; Locke I; Kote-Jarai Z; Morris JR; Solomon E; Berg J; Docherty Z; Camplejohn R; Eeles R; Hodgson SV
    Int J Cancer; 2007 Oct; 121(7):1631-6. PubMed ID: 17582599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay.
    Ernestos B; Nikolaos P; Koulis G; Eleni R; Konstantinos B; Alexandra G; Michael K
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1199-205. PubMed ID: 20206018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.
    Buchholz TA; Wu X; Hussain A; Tucker SL; Mills GB; Haffty B; Bergh S; Story M; Geara FB; Brock WA
    Int J Cancer; 2002 Feb; 97(5):557-61. PubMed ID: 11807777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
    Baeyens A; Thierens H; Claes K; Poppe B; Messiaen L; De Ridder L; Vral A
    Br J Cancer; 2002 Dec; 87(12):1379-85. PubMed ID: 12454765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
    Speit G; Trenz K
    Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity.
    Becker AA; Graeser MK; Landwehr C; Hilger T; Baus W; Wappenschmidt B; Meindl A; Weber RG; Schmutzler RK
    Breast Cancer Res Treat; 2012 Aug; 135(1):167-75. PubMed ID: 22729890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.
    Sadeghi F; Asgari M; Matloubi M; Ranjbar M; Karkhaneh Yousefi N; Azari T; Zaki-Dizaji M
    Biol Proced Online; 2020; 22():23. PubMed ID: 33013205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
    Rothfuss A; Schütz P; Bochum S; Volm T; Eberhardt E; Kreienberg R; Vogel W; Speit G
    Cancer Res; 2000 Jan; 60(2):390-4. PubMed ID: 10667592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
    Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
    Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
    Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E
    Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal radiosensitivity of triple negative breast cancer patients.
    Francies FZ; Herd O; Cairns A; Nietz S; Murdoch M; Slabbert J; Claes KBM; Vral A; Baeyens A
    Int J Radiat Biol; 2019 Nov; 95(11):1507-1516. PubMed ID: 31348739
    [No Abstract]   [Full Text] [Related]  

  • 17. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
    Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
    Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
    McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
    Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.